Forecasting the fate of stem cells

We predict how your stem cells will differentiate to help you design better experiments

Get Started

Learn More

Backed by experience from:

Genentech
UCSF
Berkeley
USC
UCLA
University of Kentucky

Backed by experience from:

Genentech
UCSF
Berkeley
USC
UCLA
University of Kentucky

Stop going in blind

Stem cells can be unpredictable—some self-renew, others mis-differentiate or die—leading to wasted time, money, and resources.

Instead of relying on trial and error, our cell fate prediction platform reduces failed experiments, and enables faster research and development.

Stop going in blind

Stem cells can be unpredictable—some self-renew, others mis-differentiate or die—leading to wasted time, money, and resources.

Instead of relying on trial and error, our cell fate prediction platform reduces failed experiments, and enables faster research and development.

Learn More

Beginning with blood

Hematopoietic stem cells (HSCs) are the source of every type of blood cell. HSC transplants are essential for treating patients with blood cancers and genetic disorders—and when paired with gene editing, they open the door to powerful new therapies. 
 
But growing these cells in the lab is unreliable. HSCs often lose their ability to self-renew and start maturing too early, making them unusable for research or treatment. 

Hematopoietic stem cells (HSCs) are the source of every type of blood cell. HSC transplants are essential for treating patients with blood cancers and genetic disorders—and when paired with gene editing, they open the door to powerful new therapies. 
 
But growing these cells in the lab is unreliable. HSCs often lose their ability to self-renew and start maturing too early, making them unusable for research or treatment. 